Alexa Woronowicz is chief copy editor for ALM and associate editor for The Legal Intelligencer. Contact her at [email protected] or on Twitter @AWoronowiczTLI.
Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular weight-loss drug. Novo Nordisk says the efforts infringe on its patent.